Dr David Farrugia

Consultant Medical Oncologist


Specialises in

My areas of specialisation include colorectal (bowel) and lung cancer, kidney cancer, melanoma, neuroendocrine (carcinoid) tumours and cancer of unknown primary (CUP). I am the local Principal Investigator in a number of clinical trials, both national and international, looking at new therapies and the role of genetics in the personalised treatment of cancer.

I was appointed in September 2000 as the first Consultant Medical Oncologist in Gloucestershire and what was then the 3 Counties Cancer Network. I qualified from the University of Malta Medical school in 1987 and underwent general medical training in London. I trained in Medical Oncology at Guy’s and St Thomas’ Hospitals, St Bart’s Hospital and The Royal Marsden Hospital in London. I read a Doctoral Thesis (PhD) on the Clinical Pharmacology of new Antifolate Cancer Drugs at the Institute of Cancer Research, Royal Marsden Hospital and University of London in 1998.

I am a member of the American Society of Clinical Oncology and the European Society of Medical Oncology, as well as specialist UK organisations for the treatment of melanoma, lung cancer and Neuroendocrine tumours. I have several publications in peer-reviewed journals and have received a merit award from the American Society of Clinical Oncology.


Treatment information

Some of the principal treatments carried out by Dr David Farrugia at Spire include:


Get in touch


Marketing Information

Spire would like to provide you with marketing information about products and services offered by Spire and by selected third-party partners. If you do not consent for us to process your personal data for marketing activities, we will still be able to contact you about your enquiry.

We may contact you by email, SMS or phone about your enquiry. If we try to contact you by phone (mobile and/or landline) and you are not available, we may leave you a voicemail message. We may also use your details to contact you about patient surveys we use for improving our service or monitoring outcomes, which are not a form of marketing.

Submit my enquiry

Additional information

Lung cancer and mesothelioma Colorectal cancer Malignant melanoma Neuroendocrine cancers Cancer of unknown primary Cancer of the kidney Targeted therapies, immunotherapy, personalised treatment using genetic and molecular profiling of cancer, treatment of rare adult cancers

Consultant Medical Oncologist, Gloucestershire Hospitals NHS Foundation Trust

Holds less than 0.1% of the shares in Spire Healthcare Group plc.
Telephone 07796 577481
Private secretary telephone 07796 577481
Private secretary email Drfarrugia.pp@nhs.net